Jun 16, 2026 06:37AM

Jun 15, 2026 06:48AM

Jun 15, 2026 05:41AM

May 13, 2026 07:50AM

May 12, 2026 09:58AM

May 11, 2026 07:54AM

Apr 29, 2026 04:12PM Intellia Therapeutics (NTLA) PT Lowered to $32 at Leerink Partners

Apr 28, 2026 04:11AM

Apr 27, 2026 02:50PM

Apr 27, 2026 01:10PM

Apr 27, 2026 11:34AM

Apr 27, 2026 10:48AM

Apr 27, 2026 10:10AM

Apr 27, 2026 07:03AM Intellia begins rolling FDA submission for gene editing therapy

Mar 4, 2026 06:01AM

Mar 3, 2026 09:54AM

Mar 3, 2026 07:30AM

Mar 3, 2026 04:56AM

Mar 2, 2026 03:25PM

Mar 2, 2026 02:48PM

Mar 2, 2026 02:18PM Intellia Therapeutics (NTLA) PT Raised to $27 at Chardan

Mar 2, 2026 02:04PM

Mar 2, 2026 12:28PM

Mar 2, 2026 12:05PM

Mar 2, 2026 10:25AM

Mar 2, 2026 10:04AM

Feb 26, 2026 01:31PM

Feb 26, 2026 01:28PM TD Cowen Reiterates Buy Rating on Intellia Therapeutics (NTLA)

Feb 26, 2026 07:35AM

Feb 3, 2026 11:35AM

Jan 28, 2026 06:39AM

Jan 27, 2026 11:29AM

Dec 19, 2025 09:06AM

Nov 11, 2025 04:31PM

Nov 11, 2025 07:17AM Jones Trading Downgrades Intellia Therapeutics (NTLA) to Hold

Nov 11, 2025 03:20AM

Nov 7, 2025 08:56AM

Nov 7, 2025 04:48AM

Nov 7, 2025 03:50AM

Nov 6, 2025 04:29PM

Nov 4, 2025 04:50PM

Oct 31, 2025 09:54AM FDA Clears Way for Faster Personalized Gene Editing Treatments

Oct 31, 2025 07:27AM

Oct 30, 2025 04:55AM

Oct 29, 2025 04:24PM

Oct 28, 2025 06:41AM

Oct 28, 2025 06:26AM

Oct 28, 2025 04:23AM

Oct 28, 2025 03:30AM William Blair Downgrades Intellia Therapeutics (NTLA) to Market Perform

Oct 28, 2025 03:30AM

416,803 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All